½ÃÀ庸°í¼­
»óǰÄÚµå
1741550

¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : Á¦°ø Á¦Ç°º°, ±â¼ú Ç÷§Æûº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Global AI in Omics Studies Market, By Offering, By Technology Platform, By Application, By End User, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀåÀº 2025³â¿¡´Â 11¾ï 1,850¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â±îÁö´Â 78¾ï 9,330¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 32.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 11¾ï 1,850¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) : 32.20% ¿¹Ãø ±Ý¾×(2032³â) 78¾ï 9,330¸¸ ´Þ·¯

¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀåÀº À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ´ë»çüÇÐ µî ´Ù¾çÇÑ ¿À¹Í½º ºÐ¾ß¿¡¼­ ÀΰøÁö´É ä¿ë Áõ°¡¿¡ ÀÇÇØ Å« ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. AI µµ±¸´Â ºòµ¥ÀÌÅÍ ºÐ¼® ¹× Á¤¹ÐÀÇ·á¿¡ ³Î¸® ÀÌ¿ëµÇ¸ç Áúº´¿¡ ´ëÇÑ ±íÀº ÀλçÀÌÆ®¸¦ ¾ò°Å³ª ȯÀÚ ¸ÂÃãÇü Ä¡·á¹ýÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¹æ´ëÇÑ ¿À¹Í½º µ¥ÀÌÅÍ ¼¼Æ®¸¦ ºÐ¼®ÇØ, º¹ÀâÇÑ ÆÐÅÏÀ» ƯÁ¤ÇÏ´Â AIÀÇ ´É·ÂÀº, â¾à ¹× ¸ÂÃãÇü Ä¡·áÁ¦ µîÀÇ ºÐ¾ß¿¡¼­ÀÇ À̿뵵 ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë AI ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ´Â ÁÖµÈ ¿äÀο¡´Â Á¦¾à ±â¾÷¿¡ ÀÇÇÑ Ã¢¾àÀ» À§ÇÑ AI¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿À¹Í½º ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ »ý¼ºµÇ´Â ¿À¹Í½º µ¥ÀÌÅÍ·® Áõ°¡ ¹× ÀÌ µ¥ÀÌÅ͸¦ È¿°úÀûÀ¸·Î Ȱ¿ëÇÒ Çʿ伺ÀÌ AIÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È ¿ì·Á, ½Å±â¼ú äÅÿ¡ ´ëÇÑ ¼Ò±ØÀû ÀÚ¼¼, ¼÷·ÃµÈ AI Àη ºÎÁ· µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡·Î¸·´Â ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí Ŭ¶ó¿ìµå ±â¹Ý ¿À¹Í½º µ¥ÀÌÅÍ ºÐ¼® Ç÷§ÆûÀÇ ÃâÇö°ú AI ¹× ÇコÄÉ¾î ºÐ¾ßÀÇ ½ÅÈï ±â¾÷ »ýŰè È®´ë´Â ½ÃÀå ±â¾÷µé¿¡°Ô Å« ¼ºÀå ±âȸ¸¦ °¡Á®´Ù ÁÙ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Â÷¼¼´ë ½ÃÄö¼­ÀÇ ÃâÇö°ú Á¤·®Àû ´Ü¹éÁúüÇÐ ¹× ´ë»çüÇÐ ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿À¹Í½º ¿¬±¸´Â ÃÖ±Ù Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº 󸮷® ±â¼úÀ» ÅëÇØ Àü·Ê ¾ø´Â ±Ô¸ð¿Í ¼Óµµ·Î ´ë·®ÀÇ ¸ÖƼ¿À¹Í½º µ¥ÀÌÅ͸¦ »ý¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. Àüü À¯Àüü ½ÃÄö½Ì ¹× Àüü ¿¢¼Ø ½ÃÄö½Ì°ú °°Àº ±â¼úÀº ¿¬±¸ ¸ñÀû»Ó¸¸ ¾Æ´Ï¶ó Áø´Ü ¹× ¿¹ÈÄ ¿¹ÃøÀ» À§ÇÑ ÀÓ»ó ÇöÀå¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸®º¸ ÇÙ»ê ½ÃÄö½Ì¿Í °°Àº ±â¼úÀº ´ÜÀÏ ¼¼Æ÷ ¼öÁØ¿¡¼­ Æ®·£½ºÅ©¸³Æ®¹«ÀÇ ÇÁ·ÎÆÄÀϸµÀ» °¡´ÉÇÏ°Ô ÇÏ°í Æ¯Á¤ ¼¼Æ÷ À¯Çü ¹× º´¸®Çаú °°Àº ¼¼ºÎ »çÇ×À» Á¦°øÇÕ´Ï´Ù. SWATH-MS¿Í °°Àº ´Ü¹éÁúüÇÐ ±â¼úÀº ´Ü¹éÁúÀÇ Ä¿¹ö¸®Áö¿Í Á¤·® ´É·ÂÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. metabolomics ±â¼úÀº ÇöÀç »ý¹°ÇÐÀû »ùÇÿ¡¼­ ¿©·¯ ´ë»ç »ê¹°À» µ¿½Ã¿¡ È®ÀÎÇϰí Á¤·®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸µÈ Á¤·®Àû ¿À¹Í½º ±â¼úÀº ¸ÖƼ¿À¹Í½º ÅëÇÕ ¿¬±¸¸¦ ÃËÁøÇÏ°í »ý¹°ÇÐÀû ½Ã½ºÅÛ¿¡ ´ëÇÑ ´õ ±íÀº ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ´ë±Ô¸ð ¹× Á¤·®ÀûÀ̰í ÅëÇÕµÈ ¿À¹Í½º µ¥ÀÌÅÍ ¼¼Æ®ÀÇ °¡¿ë¼ºÀº ÇâÈÄ ¼ö³â°£ Áúº´ ¸ÞÄ¿´ÏÁò, ¹ÙÀÌ¿À¸¶Ä¿ ¹× Ä¡·á Ç¥Àû¿¡ ´ëÇÑ Áß¿äÇÑ ¹ß°ß°ú ÀλçÀÌÆ®¸¦ ÃßÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À̰ÍÀº ´Ù¾çÇÑ Áúº´ ¿µ¿ª¿¡ °ÉÄ£ ¿À¹Í½º¿¡ ±âÃÊÇÑ ¿¬±¸ ¹× ¿ëµµÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ¹ÙÅÁÀ¸·Î ¼¼°è ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ ¹× ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ ¹× ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • ÀϰüµÈ ±âȸ Áöµµ(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÃÖ±Ù µ¿Çâ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÇÕº´, Àμö ¹× Á¦ÈÞ

Á¦4Àå ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø ¹× ¼ö¿äÃø ºÐ¼®
  • °æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : Á¦°ø Á¦Ç°º°(2020-2032³â)

  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : ±â¼ú Ç÷§Æûº°(2020-2032³â)

  • ½ÃÄö½Ì
  • ¿¡ÇÇÀ¯ÀüüÇÐ
  • ´Ü¹éÁúüÇÐ
  • ´ë»çüÇÐ
  • ±âŸ(Àü»çüÇÐ µî)

Á¦7Àå ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : ¿ëµµº°(2020-2032³â)

  • Á¾¾çÇÐ
  • °¨¿°Áõ
  • ½Å°æÇÐ
  • ½ÉÇ÷°ü Áúȯ
  • ¸é¿ªÇÐ
  • ±âŸ(¾à¸® À¯ÀüüÇÐ µî)

Á¦8Àå ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)

  • Çмú±â°ü ¹× ¿¬±¸±â°ü
  • ¹ÙÀÌ¿ÀÀǾàǰȸ»ç
  • ±âŸ(°è¾à Á¶»ç ±â°ü µî)

Á¦9Àå ¼¼°èÀÇ ¿À¹Í½º ¿¬±¸¿ë ÀΰøÁö´É(AI) ½ÃÀå : Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • À¯·´
      • µ¶ÀÏ
      • ¿µ±¹
      • ½ºÆäÀÎ
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • È£ÁÖ
      • Çѱ¹
      • ASEAN
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¸ß½ÃÄÚ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
      • GCC ±¹°¡
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó ¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Illumina
    • BGI Genomics
    • Dassault Systemes
    • Qiagen
    • Waters Corporation
    • GE Healthcare
    • Amazon Web Services, Inc
    • Bruker
    • Danaher

Á¦11Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
AJY 25.06.16

Global AI in Omics Studies Market is estimated to be valued at USD 1,118.5 Mn in 2025 and is expected to reach USD 7,893.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 32.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,118.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 32.20% 2032 Value Projection: USD 7,893.3 Mn

The global AI in omics studies market is expected to see significant growth due to the increasing adoption of artificial intelligence in various omics fields such as genomics, proteomics, and metabolomics. AI tools are being widely used for big data analytics and precision medicine to gain deeper insights into diseases and develop personalized treatment options for patients. The ability of AI to analyze massive omics datasets and identify complex patterns is also propelling its usage in areas like drug discovery and personalized therapeutics.

Market Dynamics:

The key drivers fueling the global AI in omics studies market include growing investments by pharmaceutical companies in AI for drug discovery, rising demand for precision medicine, and increasing government funding for omics research. Additionally, the growing volumes of omics data being generated and the need to leverage this data effectively are driving the adoption of AI. However, data privacy and security concerns, reluctance to adopt new technologies, and a lack of a skilled AI workforce are some of the factors hindering market growth. Meanwhile, the emergence of cloud-based omics data analytics platforms and the expansion of the startup ecosystem in the AI and healthcare spaces are expected to create significant growth opportunities for market players.

Moreover, with the advent of next-generation sequencing and advancements in quantitative proteomics and metabolomics technologies, omics studies have been revolutionized in recent years. These high-throughput technologies have enabled the generation of massive amounts of multi-omics data at an unprecedented scale and speed. Technologies like whole genome and whole exome sequencing are increasingly used not just for research purposes but also in clinical settings for diagnostics and prognostics. Technologies such as Ribonucleic acid sequencing have enabled the profiling of transcriptomes at the single-cell level, providing details into specific cell types, disease conditions, etc. Proteomics technologies like SWATH-MS have improved protein coverage and quantitation capabilities. Metabolomics technologies are now capable of identifying and quantifying several metabolites simultaneously from biological samples. These advancing quantitative omics technologies are facilitating multi-omics integration studies and providing deeper insights into biological systems. The availability of such large-scale, quantitative, and integrated omics datasets is expected to drive significant discovery and insights into disease mechanisms, biomarkers, and therapeutic targets in the coming years. This will further fuel the growth in omics based research and applications across various disease areas.

Key features of the study:

  • This report provides in-depth analysis of the global AI in omics studies market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global AI in omics studies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Illumina, BGI Genomics, Dassault Systemes, Qiagen, Waters Corporation, GE Healthcare, Amazon Web Services, Inc., Bruker, and Danaher
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global AI in omics studies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in omics studies market

Detailed Segmentation:

  • Global AI in Omics Studies Market, By Offering
    • Software
    • Services
  • Global AI in Omics Studies Market, By Technology Platform
    • Sequencing
    • Epigenomics
    • Proteomics
    • Metabolomics
    • Others (Transcriptomics, among others)
  • Global AI in Omics Studies Market, By Application
    • Oncology
    • Infectious Diseases
    • Neurology
    • Cardiovascular Diseases
    • Immunology
    • Others (Pharmacogenomics, among others)
  • Global AI in Omics Studies Market, By End User
    • Academic and Research Institutes
    • Biopharmaceutical Company
    • Others (Contract Research Organizations, among others)
  • Global AI in Omics Studies Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific.
    • Agilent Technologies
    • Illumina
    • BGI Genomics
    • Dassault Systemes
    • Qiagen
    • Waters Corporation
    • GE Healthcare
    • Amazon Web Services, Inc
    • Bruker
    • Danaher

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global AI in Omics Studies Market, By Offering
    • Global AI in Omics Studies Market, By Technology Platform
    • Global AI in Omics Studies Market, By Application
    • Global AI in Omics Studies Market, By End User
    • Global AI in Omics Studies Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing genetic/genomic data and increasing investments
    • High setup costs and lack of infrastructure
    • Scope for AI in drug discovery and vaccine development
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global AI in Omics Studies Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global AI in Omics Studies Market, By Offering, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global AI in Omics Studies Market, By Technology Platform, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Epigenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Metabolomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Transcriptomics, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global AI in Omics Studies Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Pharmacogenomics, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global AI in Omics Studies Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Biopharmaceutical Company
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Contract Research Organizations, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global AI in Omics Studies Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profile
    • Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Illumina
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BGI Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Dassault Systemes
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Qiagen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Strategies
    • Waters Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Amazon Web Services, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bruker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Danaher
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦